Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome

Clinical trial NCT01941745 · COMPLETED

Trial details

NCT number: NCT01941745
Sponsor: Tufts Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Distress Syndrome in Premature Infant Bronchopulmonary Dysplasia

Start date: 2013-10-01
Primary completion: 2017-08-25
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.